Pay in 4 interest-free payments of $7.31 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Patient Advocate Foundation www.patientadvocate.org 800-532-5274 Provides access to care, financial assistance, insurance assistance, job retention assistance, and access to the national underinsured resource directory
Pause triggers
Clinical trial populations may not fully represent the diversity of patients using semaglutide in routine practice
The GHB that comes from the labs is a synthetic version of the natural chemical compound
Although todays semaglutide market is largely OOP, falling costs could tip the scales for wider public reimbursement where insurers may be more willing to cover AOMs, in addition to simplifying coverage by removing restrictions such as prior authorisation (see section above on public reimbursement)
US$ 26.59
US$ 28.43
US$ 29.14
US$ 24.39
